Medical Review Policy

Last reviewed: 1970-01-01

RxInsider publishes pharmacy-industry intelligence — deals, negotiations, money flows, policy, and pipeline coverage. We are a B2B publication, not a consumer medical site, and our content is reported and edited by industry analysts.

Editorial standards

Every article is sourced from primary documents (SEC filings, FDA notices, CMS data, court records, company press releases) or named industry sources. We do not publish patient-directed medical advice. Where we cite clinical data, we link the underlying study and label statements as the source presents them.

Review cadence

Time-sensitive coverage (deals, negotiations, court rulings, regulatory actions) is reviewed by an industry editor before publication. Evergreen reference material — company profiles, deal trackers, and the PharmTech 100 — is reviewed quarterly for accuracy and dated Last reviewed on the page itself.

Corrections

If you spot an error in any RxInsider article — a misstated dollar figure, an outdated executive name, a mischaracterized deal term — email us through the contact page. We correct and timestamp every fix.

Not medical advice

RxInsider does not provide medical advice, diagnosis, or treatment. Nothing on this site is intended as a substitute for clinical judgment. Patients should consult a licensed clinician for medical questions and should not make prescribing or coverage decisions based on RxInsider reporting alone.